FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway

Acta Biochimica et Biophysica Sinica

Volumn 46, Issue 12, 2014, Pages 1041-1048

  Zhu, Shenglong ^a,b   Ma, Lei ^a,c   Wu, Yunzhou ^a   Ye, Xianlong ^a   Zhang, Tianyuan ^d   Zhang, Qingyang ^a   Rasoul, Lubna Muhi ^a,e   Liu, Yunye ^a   Guo, Mo ^a   Zhou, Bing ^a   Ren, Guiping ^a   Li, Deshan ^a,f  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b JIANGNAN UNIVERSITY   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

^d CHINA AGRICULTURAL UNIVERSITY   (China)

^e UNIVERSITY OF BAGHDAD   (Iraq)

^f Key Laboratory of Agricultural Biological Function Gene Northease Agricultural University   (China)

Author keywords

Alcoholic fatty liver; AMPK; Fibroblast growth factor 21 (FGF21); SIRT1

Indexed keywords

ADENYLATE KINASE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; LIPID; PRIMER DNA; REACTIVE OXYGEN METABOLITE; SIRT1 PROTEIN, MOUSE; SIRTUIN 1;

ANIMAL; BLOOD; BODY COMPOSITION; DRUG EFFECTS; ENZYME ACTIVATION; ENZYMOLOGY; FATTY LIVER, ALCOHOLIC; FEEDING BEHAVIOR; HUMAN; MALE; METABOLISM; MOUSE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ADENYLATE KINASE; ANIMALS; BASE SEQUENCE; BODY COMPOSITION; CELL LINE, TUMOR; DNA PRIMERS; ENZYME ACTIVATION; FATTY LIVER, ALCOHOLIC; FEEDING BEHAVIOR; FIBROBLAST GROWTH FACTORS; HUMANS; LIPIDS; MALE; MICE; POLYMERASE CHAIN REACTION; REACTIVE OXYGEN SPECIES; SIRTUIN 1;

EID: 84933529139     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmu097     Document Type: Article

References (26)

1. Purohit V, Gao B and Song BJ. Molecular mechanisms of alcoholic fatty liver. Alcohol Clin Exp Res 2009, 33:191-205.
2. Gao B and Bataller R. Alcoholic liver disease. Hepatology 2010, 51:07-28.
3. Sozio M and Crabb DW. Alcohol and lipid metabolism. Am J Physiol Endocrinol Metab 2008, 295:E10-E16.
4. You M, Matsumoto M, Pacold CM, Cho WK and Crabb DW. The role of AMP-activated protein kinase in the action of ethanol in the liver. Gastroenterology 2004, 127:1798-1808.
5. García-Villafranca J, Guillén A and Castro J. Ethanol consumption impairs regulation of fatty acid metabolism by decreasing the activity of AMP-activated protein kinase in rat liver. Biochimie 2008, 90:460-466.
6. Kharitonenkov A, Shiyanova TL, Koester A, Ford AM, Micanovic R, Galbreath EJ and Sandusky GE, et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005, 115:27-35.
7. Gälman C, Lundåsen T, Kharitonenkov A, Bina HA, Eriksson M, Hafström I and Dahlin M, et al. The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPAR-α activation in man. Cell Metab 2008, 8:69-74.
8. Zhu S, Ren G, Ye X, Ma L, Yu D, Han D and Li D, et al. Therapeutic effect of fibroblast growth factor 21 on NAFLD in MSG-IR mice and its mechanism. yxxb 2013, 48:1778-1784.
9. Chau MD, Gao J, Yang Q, Wu Z and Gromada J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway. Proc Natl Acad Sci USA 2010, 107:12553-12558.
10. Sun G, Ye X, Ren G, Li J and Li D. Fibroblast growth factor-21 mediates hepatic glucose metabolism of type 1 diabetes model and its mechanism. Prog Biochem Biophys 2011, 38:953-960.
11. Ki SH, Park O, Zheng M, Morales-Ibanez O, Kolls JK, Bataller R and Gao B. Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3. Hepatology 2010, 52:1291-1300.
12. Bujanda L, Hijona E, Larzabal M, Beraza M, Aldazabal P, García-Urkia N and Sarasqueta C, et al. Resveratrol inhibits nonalcoholic fatty liver disease in rats. BMC Gastroenterol 2008, 8:1-16.
13. Ohkawa H, Ohishi N and Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979, 95:351-358.
14. Ramírez-Zacarías JL, Castro-Muñozledo F and Kuri-Harcuch W. Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with Oil red O. Histochemistry 1992, 97:493-497.
15. Pochareddy S and Edenberg HJ. Chronic alcohol exposure alters gene expression in HepG2 cells. Alcohol Clin Exp Res 2012, 36:1021-1033.
16. Liu W, Yin Y, Zhou Z, He M and Dai Y. OxLDL-induced IL-1beta secretion promoting foam cells formation was mainly via CD36 mediated ROS production leading to NLRP3 inflammasome activation. Inflamm Res 2013, 63:33-43.
17. Ali F, Ranneh Y, Ismail A and Vaes B. Impaired of a non-DNA dependent methylation status decides the fat decision of bone marrow-derived C3H10T1/2 stem cell. SpringerPlus 2013, 2:1-20.
18. Sharma D, Wang J, Fu PP, Sharma S, Nagalingam A, Mells J and Handy J, et al. Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology 2010, 52:1713-1722.
19. Gao B and Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011, 141:1572-1585.
20. Helman RA, Temko MH, Nye SW and Fallon HJ. Alcoholic hepatitis. natural history and evaluation of prednisolone therapy. Ann Intern Med 1971, 74:311-321.
21. Shen Z, Liang X, Rogers CQ, Rideout D and You M. Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice. Am J Physiol Gastrointest Liver Physiol 2010, 298:364-374.
22. Itoh N and Ornitz DM. Evolution of the Fgf and Fgfr gene families. Trends Genet 2004, 20:563-569.
23. Ye Q, Ye L, Xu X, Huang B, Zhang X, Zhu Y and Chen X. Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1alpha signaling pathway. BMC Complement Altern Med 2012, 12:1-13.
24. Feng X, Jiang Y, Meltzer P and Yen PM. Thyroid hormone regulation of hepatic genes in vivo detected by complementary DNA microarray. Mol Endocrinol 2000, 14:947-955.
25. Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD and Crabb DW. Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology 2003, 37:544-550.
26. García-Ruiz C, Colell A, Morales A, Kaplowitz N and Fernández-Checa JC. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol 1995, 48:825-834.